Work

Curing Atherosclerosis Should Be the Next Major Cardiovascular Prevention Goal

Year: 2014

Type: article

Source: Journal of the American College of Cardiology

DOI: 10.1016/j.jacc.2014.04.009

Authors: Jennifer G. Robinson, Samuel S. Gidding

Institutions: University of Iowa, Alfred I. duPont Hospital for Children, Thomas Jefferson University

Language: English

Topic: Lipoproteins and Cardiovascular Health

Subfield: Cardiology and Cardiovascular Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

Funders: Amgen, Eli Lilly and Company, Pfizer, AstraZeneca, GlaxoSmithKline, Sanofi, Regeneron Pharmaceuticals, Amarin Corporation, Daiichi-Sankyo, Esperion Therapeutics, Genentech, National Institute of General Medical Sciences

Award: Delaware Clinical and Translational Research ACCEL Program

OpenAlex ID: W2064407018

FWCI: 10.03

Cites: 49

Cited by: 88

Related to: 10